(Q40715705)

23 September 2017

title

High level expression of recombinant porcine coagulation factor VIII. (English)

1 reference

23 September 2017

author name string

Christopher B Doering

1

1 reference

23 September 2017

John F Healey

2

1 reference

23 September 2017

Ernest T Parker

3

1 reference

23 September 2017

Rachel T Barrow

4

1 reference

23 September 2017

Pete Lollar

5

1 reference

23 September 2017

language of work or name

English

0 references

publication date

23 July 2002

1 reference

Journal of Biological Chemistry

23 September 2017

published in

1 reference

23 September 2017

volume

277

1 reference

23 September 2017

issue

41

1 reference

23 September 2017

page(s)

38345-38349

1 reference

Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206959200

rFactor VIII deficit questioned

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206959200

A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206959200

Antigenicity of putative phospholipid membrane-binding residues in factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206959200

Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. BioTechniques 8(5):528-535 (November 1990).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206959200

Eukaryotic protein processing: endoproteolysis of precursor proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206959200

Expression of the amino-terminal half-molecule of human serum transferrin in cultured cells and characterization of the recombinant protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206959200

Molecular cloning of a cDNA encoding human antihaemophilic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206959200

Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206959200

How to measure and predict the molar absorption coefficient of a protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206959200

Sequences in the coding region of clotting factor VIII act as dominant inhibitors of RNA accumulation and protein production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206959200

Sequences within the coding regions of clotting factor VIII and CFTR block transcriptional elongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206959200

The interaction of the calcium- and integrin-binding protein (CIBP) with the coagulation factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206959200

Differential interaction of coagulation factor VIII and factor V with protein chaperones calnexin and calreticulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206959200

ATP-dependent dissociation of non-disulfide-linked aggregates of coagulation factor VIII is a rate-limiting step for secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206959200

Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206959200

Development and analysis of retroviral vectors expressing human factor VIII as a potential gene therapy for hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206959200

Characterization of the human factor VIII gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206959200

Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIa

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206959200

21 January 2018

Identifiers

DOI

10.1074/JBC.M206959200

1 reference

23 September 2017

1 reference